CARIS MPI, INC.
IRVING, TX

Caris MPI, Inc., established in December 2010 and incorporated in Texas with the filing number F10000005433, is headquartered at 750 W John Carpenter Freeway, Suite 800, Irving, TX. The company specializes as a pioneer in tumor profiling, leveraging advanced molecular science to drive precision medicine forward. In July 2023, Nature Communications highlighted Caris Life Sciences' innovative ADAPT Biotargeting System, which significantly surpassed the industry standard for HER2 testing. This achievement underlines Caris MPI, Inc.'s commitment to research and development excellence in oncology. The company holds a 'FORP' designation indicating its purpose as an international business corporation. It maintains compliance with regional regulations, filing regularly with Broward County, Florida, where it also possesses the status of Florida.Models.Dos.FloridaCompanyStatus. Important events such as amendments to its corporate structure have been documented, with the latest recorded on January 16, 2018. As for governance and leadership, key individuals include David D. Halbert (Chief Executive Officer) and Stephanie S. Thomas (Director), supported by J.R. Denton in a secretarial capacity. Caris MPI, Inc. continues to contribute substantially to the field of cancer treatment with its dedication to personalized medicine solutions, aligning clinical practices with cutting-edge genetic information processing. The company can be contacted via several channels, including phone numbers (888) 979-8669, (866) 771-8946, and (214) 294-5690 for inquiries or collaborations. For more details, interested parties are encouraged to visit its website at carismpi.com.